×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Forty Seven, Inc.. (FTSV) NASDAQ

$95.51 - (-)

Market Cap: $4.60B

As of 04/06/20 12:00 AM EDT. Market closed.

(FTSV)

Forty Seven, Inc.. (FTSV)
NASDAQ

$95.51
- (-)

Market Cap: $4.60B

As of 04/06/20 12:00 AM EDT. Market closed.

Add to Portfolio

Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, ... read more

Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA. read less

COMPANY PROFILE
Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO Compensation (Base)
$453,556
CEO Compensation (Total)
$1.75M
URL
Address
1490 O'Brien Drive, CA, Menlo Park, 94025.
Sector
Health Technology
Industry
Pharmaceuticals: Major
Full Time Employees
68
CEO Compensation (Base)
$453,556
CEO Compensation (Total)
$1.75M
Address
1490 O'Brien Drive, CA, Menlo Park, 94025.
PRICE CHART FOR FORTY SEVEN, INC.
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$95.51
Days Range
- - -
52 week range
$5.53 - $95.52
Volume
0
Avg. Volume (30 days)
2,816,220
Market Cap
$4.60B
Dividend Yield
-
P/E
-
Shares Outstanding
48,156,000
Open
-
Previous Close
$95.51
Days Range
- - -
52 week range
$5.53 - $95.52
Volume
0
Avg. Volume (30 days)
2,816,220
Market Cap
$4.60B
Dividend Yield
-
P/E
-
Shares Outstanding
48,156,000
FINANCIAL STATEMENTS FOR FORTY SEVEN, INC.
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR FORTY SEVEN, INC.
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Takimoto Chris HChief Medical OfficerApr 01, 2020 Option Exercise$4.7779,195377,66683,101Apr 03, 2020, 05:53 PM
Takimoto Chris HChief Medical OfficerApr 01, 2020 Sale$95.4279,1957,556,7873,906Apr 03, 2020, 05:53 PM
RHOADS ANN DChief Financial OfficerApr 01, 2020 Option Exercise$8.7620,950183,47039,338Apr 03, 2020, 05:51 PM
RHOADS ANN DChief Financial OfficerApr 01, 2020 Sale$95.431,924183,59837,414Apr 03, 2020, 05:51 PM
McCamish Mark AnthonyPresident and CEOApr 01, 2020 Option Exercise$4.8830,237147,63237,172Apr 03, 2020, 05:50 PM
McCamish Mark AnthonyPresident and CEOApr 01, 2020 Sale$95.4232,5773,108,50434,832Apr 03, 2020, 05:50 PM
WEISSMAN IRVINGDirectorMar 12, 2020 Sale$93.0653,0954,941,2611,795,056Mar 16, 2020, 06:01 AM
WEISSMAN IRVINGDirectorMar 11, 2020 Sale$94.72196,90518,650,2111,805,856Mar 16, 2020, 06:01 AM
Majeti RavindraDirectorFeb 18, 2020 Sale$44.3825,0001,109,5141,080,688Feb 19, 2020, 06:18 PM
Majeti RavindraDirectorJan 15, 2020 Sale$36.3525,000908,6981,087,411Jan 16, 2020, 09:21 PM
WEISSMAN IRVINGDirectorDec 26, 2019 Sale$44.2230,0001,326,6812,008,876Dec 30, 2019, 05:56 PM
Majeti RavindraDirectorDec 16, 2019 Sale$35.4925,000887,1681,118,404Dec 17, 2019, 07:29 PM
Takimoto Chris HChief Medical OfficerDec 10, 2019 Option Exercise$2.0210,00020,15010,000Dec 11, 2019, 09:57 PM
Takimoto Chris HChief Medical OfficerDec 10, 2019 Sale$35.0010,000350,0000Dec 11, 2019, 09:57 PM
Takimoto Chris HChief Medical OfficerDec 09, 2019 Option Exercise$2.0210,00020,15010,000Dec 10, 2019, 09:53 PM
Takimoto Chris HChief Medical OfficerDec 09, 2019 Sale$30.0010,000300,0000Dec 10, 2019, 09:53 PM
WEISSMAN IRVINGDirectorDec 09, 2019 Sale$16.2220,000324,4092,042,941Dec 10, 2019, 09:52 PM
Majeti RavindraDirectorDec 09, 2019 Sale$19.6265,0001,275,0001,196,400Dec 10, 2019, 09:51 PM
Majeti RavindraDirectorNov 20, 2019 Sale$12.505,00062,5001,201,400Nov 22, 2019, 06:57 PM
Majeti RavindraDirectorNov 18, 2019 Sale$10.2615,000153,9151,206,400Nov 20, 2019, 08:01 PM
Takimoto Chris HChief Medical OfficerAug 16, 2019 Sale$6.366634,2160Aug 21, 2019, 11:37 AM
Lightspeed Venture Partners X, L.P.10% OwnerJul 22, 2019 Buy$8.00312,5002,500,0002,096,769Jul 24, 2019, 04:57 PM
Lightspeed Venture Partners X, L.P.10% OwnerJul 22, 2019 Buy$8.00312,5002,500,0002,786,868Jul 24, 2019, 04:57 PM
BIRD JEFFREY WDirectorJul 22, 2019 Buy$8.00187,5001,500,000192,419Jul 24, 2019, 04:06 PM
BIRD JEFFREY WDirectorJul 22, 2019 Buy$8.00562,5004,500,000562,500Jul 24, 2019, 04:06 PM
McCamish Mark AnthonyPresident and CEOJun 25, 2019 Option Exercise$4.888,19940,03268,918Jun 27, 2019, 06:22 PM
McCamish Mark AnthonyPresident and CEOJun 25, 2019 Sale$11.028,19990,39160,719Jun 27, 2019, 06:22 PM
McCamish Mark AnthonyPresident and CEOJun 20, 2019 Option Exercise$4.888,30140,53069,020Jun 24, 2019, 05:39 PM
McCamish Mark AnthonyPresident and CEOJun 20, 2019 Sale$11.048,30191,62660,719Jun 24, 2019, 05:39 PM
McCamish Mark AnthonyPresident and CEOMay 20, 2019 Option Exercise$4.8816,50080,56175,928May 22, 2019, 08:15 PM
McCamish Mark AnthonyPresident and CEOMay 20, 2019 Sale$12.1016,500199,72660,719May 22, 2019, 08:15 PM
Majeti RavindraDirectorMay 16, 2019 Sale$16.022,08833,4601,421,400May 17, 2019, 06:56 PM
Majeti RavindraDirectorMay 15, 2019 Sale$16.012,22335,5841,423,488May 17, 2019, 06:56 PM
Takimoto Chris HChief Medical OfficerMay 03, 2019 Option Exercise$2.028,00016,1208,000May 07, 2019, 07:33 PM
Takimoto Chris HChief Medical OfficerMay 03, 2019 Sale$17.998,000143,9510May 07, 2019, 07:33 PM
WEISSMAN IRVINGDirectorApr 26, 2019 Sale$18.3520,000366,9782,052,761Apr 30, 2019, 07:05 PM
McCamish Mark AnthonyPresident and CEOApr 18, 2019 Option Exercise$4.8816,50080,56177,219Apr 22, 2019, 08:21 PM
McCamish Mark AnthonyPresident and CEOApr 18, 2019 Sale$18.1216,500299,05460,719Apr 22, 2019, 08:21 PM
Majeti RavindraDirectorApr 15, 2019 Sale$18.3025,000457,5051,425,711Apr 17, 2019, 07:35 PM
Takimoto Chris HChief Medical OfficerApr 04, 2019 Option Exercise$2.028,00016,1208,000Apr 08, 2019, 07:20 PM
Takimoto Chris HChief Medical OfficerApr 04, 2019 Sale$16.398,000131,1050Apr 08, 2019, 07:20 PM
WEISSMAN IRVINGDirectorApr 05, 2019 Sale$17.156,518111,7992,072,761Apr 05, 2019, 07:07 PM
WEISSMAN IRVINGDirectorApr 03, 2019 Sale$17.043,38257,6322,079,279Apr 05, 2019, 07:07 PM
WEISSMAN IRVINGDirectorMar 29, 2019 Sale$18.001001,8002,082,661Apr 02, 2019, 08:01 PM
WEISSMAN IRVINGDirectorMar 26, 2019 Sale$15.9810,000159,8122,082,761Mar 28, 2019, 07:27 PM
McCamish Mark AnthonyPresident and CEOMar 19, 2019 Option Exercise$4.8816,50080,56177,219Mar 21, 2019, 08:42 PM
McCamish Mark AnthonyPresident and CEOMar 19, 2019 Sale$18.1516,500299,40160,719Mar 21, 2019, 08:42 PM
Majeti RavindraDirectorMar 19, 2019 Sale$18.035,29295,3981,450,711Mar 19, 2019, 07:23 PM
Majeti RavindraDirectorMar 18, 2019 Sale$18.029,708174,9381,456,003Mar 19, 2019, 07:23 PM
Majeti RavindraDirectorMar 15, 2019 Sale$17.6820,000353,6161,465,711Mar 19, 2019, 07:23 PM
Takimoto Chris HChief Medical OfficerMar 04, 2019 Option Exercise$2.028,00016,1208,000Mar 06, 2019, 08:55 PM
Takimoto Chris HChief Medical OfficerMar 04, 2019 Sale$16.948,000135,5500Mar 06, 2019, 08:55 PM
WEISSMAN IRVINGDirectorMar 01, 2019 Sale$17.043,61661,6032,092,761Mar 05, 2019, 07:25 PM
WEISSMAN IRVINGDirectorFeb 26, 2019 Sale$16.9312,104204,9732,100,657Feb 27, 2019, 09:09 PM
WEISSMAN IRVINGDirectorFeb 25, 2019 Sale$17.0310,000170,3252,112,761Feb 27, 2019, 09:09 PM
WEISSMAN IRVINGDirectorFeb 27, 2019 Sale$17.014,28072,8052,096,377Feb 27, 2019, 09:09 PM
Majeti RavindraDirectorFeb 25, 2019 Sale$16.0710,266164,9901,485,711Feb 26, 2019, 06:23 PM
Majeti RavindraDirectorFeb 22, 2019 Sale$16.0122,371358,1311,495,977Feb 26, 2019, 06:23 PM
McCamish Mark AnthonyPresident and CEOFeb 19, 2019 Option Exercise$4.887,09034,61767,809Feb 21, 2019, 07:51 PM
McCamish Mark AnthonyPresident and CEOFeb 20, 2019 Option Exercise$4.889,41045,94470,129Feb 21, 2019, 07:51 PM
McCamish Mark AnthonyPresident and CEOFeb 19, 2019 Sale$15.067,090106,79760,719Feb 21, 2019, 07:51 PM
McCamish Mark AnthonyPresident and CEOFeb 20, 2019 Sale$14.949,410140,54660,719Feb 21, 2019, 07:51 PM
Takimoto Chris HChief Medical OfficerFeb 19, 2019 Sale$15.052,50037,6210Feb 21, 2019, 07:45 PM
Takimoto Chris HChief Medical OfficerFeb 04, 2019 Option Exercise$2.028,00016,1208,000Feb 05, 2019, 07:02 PM
Takimoto Chris HChief Medical OfficerFeb 04, 2019 Sale$14.868,000118,8740Feb 05, 2019, 07:02 PM
WEISSMAN IRVINGDirectorFeb 04, 2019 Sale$15.026,44596,8052,122,761Feb 05, 2019, 07:00 PM
WEISSMAN IRVINGDirectorFeb 01, 2019 Sale$15.023,21948,3622,129,206Feb 05, 2019, 07:00 PM
Majeti RavindraDirectorJan 31, 2019 Sale$14.573,83455,8721,518,348Feb 01, 2019, 06:29 PM
Majeti RavindraDirectorJan 30, 2019 Sale$14.4616,166233,6831,522,182Feb 01, 2019, 06:29 PM
WEISSMAN IRVINGDirectorJan 28, 2019 Sale$15.003365,0412,132,425Jan 30, 2019, 07:10 PM
McCamish Mark AnthonyPresident and CEOJan 25, 2019 Option Exercise$4.8851,687252,36260,719Jan 29, 2019, 07:38 PM
McCamish Mark AnthonyPresident and CEOJan 18, 2019 Option Exercise$4.8820,00097,65029,032Jan 23, 2019, 07:42 PM
McCamish Mark AnthonyPresident and CEOJan 18, 2019 Sale$14.5920,000291,8929,032Jan 23, 2019, 07:42 PM
Majeti RavindraDirectorJan 16, 2019 Sale$16.004,36369,8221,538,348Jan 17, 2019, 07:58 PM
Majeti RavindraDirectorJan 15, 2019 Sale$15.7323,000361,8081,542,711Jan 17, 2019, 07:58 PM
WEISSMAN IRVINGDirectorJan 09, 2019 Sale$17.0510,000170,4902,132,761Jan 11, 2019, 08:13 PM
WEISSMAN IRVINGDirectorDec 26, 2018 Sale$15.7710,000157,6852,143,823Jan 11, 2019, 08:11 PM
Takimoto Chris HChief Medical OfficerJan 04, 2019 Option Exercise$2.028,00016,1208,000Jan 08, 2019, 08:17 PM
Takimoto Chris HChief Medical OfficerJan 04, 2019 Sale$15.558,000124,3620Jan 08, 2019, 08:17 PM
McCamish Mark AnthonyPresident and CEODec 26, 2018 Option Exercise$4.8812,00058,59021,032Dec 28, 2018, 05:37 PM
McCamish Mark AnthonyPresident and CEODec 26, 2018 Sale$15.9012,000190,80612,000Dec 28, 2018, 05:37 PM
Mhatre Ravi10% OwnerAug 22, 2018 Buy$14.9744,000658,85644,000Aug 24, 2018, 06:38 PM
Mhatre Ravi10% OwnerAug 23, 2018 Buy$15.2711,372173,66333,372Aug 24, 2018, 06:38 PM
Mhatre Ravi10% OwnerAug 23, 2018 Buy$15.2722,743347,31166,743Aug 24, 2018, 06:38 PM
Mhatre Ravi10% OwnerAug 23, 2018 Buy$15.2722,743347,31166,743Aug 24, 2018, 06:38 PM
Mhatre Ravi10% OwnerAug 22, 2018 Buy$14.9722,000329,42822,000Aug 24, 2018, 06:38 PM
Mhatre Ravi10% OwnerAug 22, 2018 Buy$14.9744,000658,85644,000Aug 24, 2018, 06:38 PM
Nieh Peter10% OwnerAug 17, 2018 Buy$14.962,50037,40067,500Aug 20, 2018, 06:51 PM
Nieh Peter10% OwnerAug 16, 2018 Buy$15.1965,000987,49365,000Aug 20, 2018, 06:51 PM
SCHAEPE CHRISTOPHER JDirectorAug 16, 2018 Buy$15.0366,5421,000,01366,542Aug 20, 2018, 06:15 PM
WHITE JAMES N10% OwnerJul 02, 2018 Buy$16.007,415118,64037,254Jul 03, 2018, 07:42 PM
WHITE JAMES N10% OwnerJul 02, 2018 Buy$16.00134,7352,155,7602,906,372Jul 03, 2018, 07:42 PM
SUTTER HILL VENTURESFormer 10% HolderJul 02, 2018 Buy$16.00134,7352,155,7602,906,372Jul 03, 2018, 07:42 PM
Speiser Michael L10% OwnerJul 02, 2018 Buy$16.005,74591,92067,417Jul 03, 2018, 07:42 PM
Speiser Michael L10% OwnerJul 02, 2018 Buy$16.00134,7352,155,7602,906,372Jul 03, 2018, 07:42 PM
Pullara Samuel J IIIFormer 10% HolderJul 02, 2018 Buy$16.002,05932,94441,829Jul 03, 2018, 07:42 PM
Pullara Samuel J IIIFormer 10% HolderJul 02, 2018 Buy$16.00134,7352,155,7602,906,372Jul 03, 2018, 07:42 PM
Dyckerhoff Stefan AFormer 10% HolderJul 02, 2018 Buy$16.001,91530,64041,305Jul 03, 2018, 07:42 PM
Dyckerhoff Stefan AFormer 10% HolderJul 02, 2018 Buy$16.00134,7352,155,7602,906,372Jul 03, 2018, 07:42 PM
COXE TENCH10% OwnerJul 02, 2018 Buy$16.0018,314293,024126,050Jul 03, 2018, 07:42 PM
COXE TENCH10% OwnerJul 02, 2018 Buy$16.00134,7352,155,7602,906,372Jul 03, 2018, 07:42 PM
BIRD JEFFREY WDirectorJul 02, 2018 Buy$16.004,25268,0324,252Jul 03, 2018, 07:42 PM
BIRD JEFFREY WDirectorJul 02, 2018 Buy$16.00134,7352,155,7602,906,372Jul 03, 2018, 07:42 PM
Lightspeed Venture Partners Select II, L.P.10% OwnerJul 02, 2018 Buy$16.00468,7507,500,0001,784,269Jul 02, 2018, 05:16 PM
SCHAEPE CHRISTOPHER JDirectorJul 02, 2018 Buy$16.00468,7507,500,0001,784,269Jul 02, 2018, 05:14 PM
Clarus Lifesciences III, L.P.10% OwnerJul 02, 2018 Buy$16.00200,0003,200,0003,816,951Jul 02, 2018, 05:14 PM
HENNER DENNISDirectorJul 02, 2018 Buy$16.00200,0003,200,0003,816,951Jul 02, 2018, 05:13 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Takimoto Chris HChief Medical Officer04/01/2020377,666
Takimoto Chris HChief Medical Officer04/01/20207,556,787
RHOADS ANN DChief Financial Officer04/01/2020183,470
RHOADS ANN DChief Financial Officer04/01/2020183,598
McCamish Mark AnthonyPresident and CEO04/01/2020147,632
McCamish Mark AnthonyPresident and CEO04/01/20203,108,504
WEISSMAN IRVINGDirector03/12/20204,941,261
WEISSMAN IRVINGDirector03/11/202018,650,211
Majeti RavindraDirector02/18/20201,109,514
Majeti RavindraDirector01/15/2020908,698
WEISSMAN IRVINGDirector12/26/20191,326,681
Majeti RavindraDirector12/16/2019887,168
Takimoto Chris HChief Medical Officer12/10/201920,150
Takimoto Chris HChief Medical Officer12/10/2019350,000
Takimoto Chris HChief Medical Officer12/09/201920,150
Takimoto Chris HChief Medical Officer12/09/2019300,000
WEISSMAN IRVINGDirector12/09/2019324,409
Majeti RavindraDirector12/09/20191,275,000
Majeti RavindraDirector11/20/201962,500
Majeti RavindraDirector11/18/2019153,915
Takimoto Chris HChief Medical Officer08/16/20194,216
Lightspeed Venture Partners X, L.P.10% Owner07/22/20192,500,000
Lightspeed Venture Partners X, L.P.10% Owner07/22/20192,500,000
BIRD JEFFREY WDirector07/22/20191,500,000
BIRD JEFFREY WDirector07/22/20194,500,000
McCamish Mark AnthonyPresident and CEO06/25/201940,032
McCamish Mark AnthonyPresident and CEO06/25/201990,391
McCamish Mark AnthonyPresident and CEO06/20/201940,530
McCamish Mark AnthonyPresident and CEO06/20/201991,626
McCamish Mark AnthonyPresident and CEO05/20/201980,561
McCamish Mark AnthonyPresident and CEO05/20/2019199,726
Majeti RavindraDirector05/16/201933,460
Majeti RavindraDirector05/15/201935,584
Takimoto Chris HChief Medical Officer05/03/201916,120
Takimoto Chris HChief Medical Officer05/03/2019143,951
WEISSMAN IRVINGDirector04/26/2019366,978
McCamish Mark AnthonyPresident and CEO04/18/201980,561
McCamish Mark AnthonyPresident and CEO04/18/2019299,054
Majeti RavindraDirector04/15/2019457,505
Takimoto Chris HChief Medical Officer04/04/201916,120
Takimoto Chris HChief Medical Officer04/04/2019131,105
WEISSMAN IRVINGDirector04/05/2019111,799
WEISSMAN IRVINGDirector04/03/201957,632
WEISSMAN IRVINGDirector03/29/20191,800
WEISSMAN IRVINGDirector03/26/2019159,812
McCamish Mark AnthonyPresident and CEO03/19/201980,561
McCamish Mark AnthonyPresident and CEO03/19/2019299,401
Majeti RavindraDirector03/19/201995,398
Majeti RavindraDirector03/18/2019174,938
Majeti RavindraDirector03/15/2019353,616
Takimoto Chris HChief Medical Officer03/04/201916,120
Takimoto Chris HChief Medical Officer03/04/2019135,550
WEISSMAN IRVINGDirector03/01/201961,603
WEISSMAN IRVINGDirector02/26/2019204,973
WEISSMAN IRVINGDirector02/25/2019170,325
WEISSMAN IRVINGDirector02/27/201972,805
Majeti RavindraDirector02/25/2019164,990
Majeti RavindraDirector02/22/2019358,131
McCamish Mark AnthonyPresident and CEO02/19/201934,617
McCamish Mark AnthonyPresident and CEO02/20/201945,944
McCamish Mark AnthonyPresident and CEO02/19/2019106,797
McCamish Mark AnthonyPresident and CEO02/20/2019140,546
Takimoto Chris HChief Medical Officer02/19/201937,621
Takimoto Chris HChief Medical Officer02/04/201916,120
Takimoto Chris HChief Medical Officer02/04/2019118,874
WEISSMAN IRVINGDirector02/04/201996,805
WEISSMAN IRVINGDirector02/01/201948,362
Majeti RavindraDirector01/31/201955,872
Majeti RavindraDirector01/30/2019233,683
WEISSMAN IRVINGDirector01/28/20195,041
McCamish Mark AnthonyPresident and CEO01/25/2019252,362
McCamish Mark AnthonyPresident and CEO01/18/201997,650
McCamish Mark AnthonyPresident and CEO01/18/2019291,892
Majeti RavindraDirector01/16/201969,822
Majeti RavindraDirector01/15/2019361,808
WEISSMAN IRVINGDirector01/09/2019170,490
WEISSMAN IRVINGDirector12/26/2018157,685
Takimoto Chris HChief Medical Officer01/04/201916,120
Takimoto Chris HChief Medical Officer01/04/2019124,362
McCamish Mark AnthonyPresident and CEO12/26/201858,590
McCamish Mark AnthonyPresident and CEO12/26/2018190,806
Mhatre Ravi10% Owner08/22/2018658,856
Mhatre Ravi10% Owner08/23/2018173,663
Mhatre Ravi10% Owner08/23/2018347,311
Mhatre Ravi10% Owner08/23/2018347,311
Mhatre Ravi10% Owner08/22/2018329,428
Mhatre Ravi10% Owner08/22/2018658,856
Nieh Peter10% Owner08/17/201837,400
Nieh Peter10% Owner08/16/2018987,493
SCHAEPE CHRISTOPHER JDirector08/16/20181,000,013
WHITE JAMES N10% Owner07/02/2018118,640
WHITE JAMES N10% Owner07/02/20182,155,760
SUTTER HILL VENTURESFormer 10% Holder07/02/20182,155,760
Speiser Michael L10% Owner07/02/201891,920
Speiser Michael L10% Owner07/02/20182,155,760
Pullara Samuel J IIIFormer 10% Holder07/02/201832,944
Pullara Samuel J IIIFormer 10% Holder07/02/20182,155,760
Dyckerhoff Stefan AFormer 10% Holder07/02/201830,640
Dyckerhoff Stefan AFormer 10% Holder07/02/20182,155,760
COXE TENCH10% Owner07/02/2018293,024
COXE TENCH10% Owner07/02/20182,155,760
BIRD JEFFREY WDirector07/02/201868,032
BIRD JEFFREY WDirector07/02/20182,155,760
Lightspeed Venture Partners Select II, L.P.10% Owner07/02/20187,500,000
SCHAEPE CHRISTOPHER JDirector07/02/20187,500,000
Clarus Lifesciences III, L.P.10% Owner07/02/20183,200,000
HENNER DENNISDirector07/02/20183,200,000
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR FORTY SEVEN, INC.
LOADING...